ArticleJournal of maxillofacial and oral surgery2024
Proactive Customized Protocol for Oral Management in Head and Neck Cancer Patients Planned for Radiotherapy.
Article in Journal of maxillofacial and oral surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reply to "Proactive Customized Protocol for Oral Management in Head and Neck Cancer Patients Planned for Radiotherapy".Journal of maxillofacial and oral surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoradionecrosis (ORN) is a nemesis of radiotherapy which adversely affects the life of an individual. It is more often seen with conventional external beam radiotherapy using telecobalt machine. Newer radiotherapy techniques are being used in developed nations to circumvent its inherent disadvantages. A higher incidence of ORN is seen in dentate jaws because of extractions done for odontogenic infections in the post radiation period. Systematic evaluation of oral tissues and instituting appropriate therapeutic and prophylactic measures before, during and after completion of radiotherapy is mandatory. In our hospital since we use telecobalt radiotherapy it was deemed necessary to design our own protocol to reduce the incidence of this debilitating complication. Our protocol is based on recommended guidelines and which has been customized to our patient strata. We present the findings of a retrospective study on patients undergoing radiotherapy in whom this oral management protocol was used. This protocol has been effective in reducing the frequency of osteoradionecrosis at our tertiary care hospital.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.